FIELD: chemistry.
SUBSTANCE: invention refers to novel compound with inhibition effect on FAAH enzyme, corresponding to the general formula (I) where variables m, n, X, R1 and R2, R3, R4 and Y variables take values provided in the claim; to method of compound obtainment, and to compound application in therapy, and to pharmaceutical composition including compound of the formula (I).
EFFECT: improved method.
12 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ARYL- AND HETEROARYLPIPERIDINECARBOXYLATES, THEIR PRODUCTION AND THEIR USE AS INHIBITORS OF FAAH FERMENT | 2005 |
|
RU2376305C2 |
HETEROARYLALKYLCARBAMATE DERIVATIVES, THEIR OBTAINING AND THEIR APPLICATION AS ENZYME FAAH INHIBITORS | 2005 |
|
RU2364586C2 |
DERIVATIVES OF ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINECARBOXYLATES, OBTAINING THEM AND THEIR USE AS FERMENT FAAH INHIBITORS | 2005 |
|
RU2331637C2 |
PIPERIDINE ALKYL CARBAMATE DERIVATIVES, PRODUCTION THEREOF AND USE THEREOF AS FAAH ENZYME INHIBITORS | 2005 |
|
RU2384569C2 |
DERIVATIVES OF 1-PIPERAZINE- AND 1-HOMOPIPERAZINCARBOXILATES, THEIR OBTAINING AND USE | 2004 |
|
RU2356890C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
STIMULATING AGENTS OF GROWTH HORMONE SECRETION | 1996 |
|
RU2172742C2 |
CYCLIC AMINE DERIVATIVES, OBTAINMENT METHODS, AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2004 |
|
RU2392270C2 |
SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH DERIVATIVE | 2006 |
|
RU2394560C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND | 1993 |
|
RU2130453C1 |
Authors
Dates
2010-06-20—Published
2005-01-07—Filed